CAS: 207679-81-0; 5-Hydroxymethyl Tolterodine

该化合物是一种主要用于治疗过活性膀胱综合征(OAB)的药用活性异狄氏物,作为一种抗氨酸剂,它有选择地抑制M3受体亚型,减少非自愿分泌肌肉收缩,缓解尿急性,频率和失禁等症状,其主要优势包括可预期的药用动动因特征,具有一致的生物利用率,而且由于绕过CYP2D6酶,代谢变异性极小.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号156755-37-2 3-[(1R)-3-[二(异丙... | CAS号1294517-15-9 3-[(1R)-3-Bisis... | CAS号108-18-9 二异丙胺 | CAS号1333234-72-2 (R)-2-[3-(diiso... | CAS号200801-70-3 2-(3-(二异丙氨基)-1-... | CAS号214601-12-4 3-[(1R)-3-[双(1-... | CAS号99-76-3 尼泊金甲酯 | CAS号286930-02-7 弗斯特罗定 | CAS号1208313-13-6 O-异丁酰基(R)-非索罗定 | CAS号380636-50-0 (R)-2-[3-二异丙氨基乙...

合成工艺路线路线简述

  • 51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3
    反应条件:1.1 Solvents: 2-Methyl-2-Butanol; 2 H,70 °C; 1 H,70 - 75 °C; 1 H,75 °C -> 65 °C; 2 H,60 °C; 60 °C -> 25 °C; 12 H,25 °C
    标题:Process For The Preparation Of 2-Hydroxy-4-Phenyl-3,4-Dihydro-2H-Chromen-6-Ylmethanol And (R)-2-[3-(Diisopropylamino)-1-Phenylpropyl]-4-(Hydroxymethyl)Phenol As As Fesoterodine Precursors
    参考文献:World Intellectual Property Organization]

    51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3
    反应条件:1.1 Solvents: 2-Methyl-2-Butanol; 70 °C
    标题:The Lactol Route To Fesoterodine: An Amine-Promoted Friedel-Crafts Alkylation On Commercial Scale
    作者:Dirat,Olivier; Bibb,Andrew J.; Burns,Colin M.; Checksfield,Graham D.; Dillon,Barry R.; Et Al
    参考文献:Organic Process Research & Development 日期:2011 卷标:15(5) 页码:1010-1017]

    51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3
    反应条件:1.1 Solvents: Tetrahydrofuran; 50 - 55 °C; 6 H,25 - 30 °C; 30 °C -> 15 °C; 2 - 3 H,10 - 15 °C
    标题:Method For Preparation Of Fesoterodine And Its Pharmaceutically Acceptable Salts For Treatment Of Urinary Incontinence
    参考文献:World Intellectual Property Organization]

    = 207679-81-0 + 51019-43-3 [标题:Reaction Conditions
    标题:Process For The Production Of Benzopyran-2-Ol Derivatives
    参考文献:United States]

    51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3
    反应条件:1.1 Solvents: 2-Methyl-2-Butanol; 2 H,70 °C; 1 H,70 - 75 °C
    标题:Process For The Preparation Of 2-Hydroxy-4-Phenyl-3,4-Dihydro-2H-Chromen-6-Ylmethanol And (R)-2-[3-(Diisopropylamino)-1-Phenylpropyl]-4-(Hydroxymethyl)Phenol As Fesoterodine Precursors
    参考文献:Italy]

    51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3
    反应条件:1.1 Solvents: Tetrahydrofuran; 15 Min,Rt; Rt -> 55 °C
    标题:New Uses Of Diisopropylamine Derivatives
    参考文献:World Intellectual Property Organization]

    51019-43-3 + 200801-70-3 = 207679-81-0 + 51019-43-3
    反应条件:1.1 Solvents: Ethyl Acetate; 5 - 6 H,55 °C; 55 °C -> 30 °C; 25 - 30 °C
    标题:Process For The Preparation Of Fesoterodine And Intermediates
    参考文献:World Intellectual Property Organization]

    = 207679-81-0 + 51019-43-3 [标题:Reaction Conditions
    标题:Process For The Preparation Of 2-Hydroxy-4-Phenyl-3,4-Dihydro-2H-Chromen-6-Yl-Methanol And (R)-Feso-Deacyl
    参考文献:United States
(R)-[4-Benzyloxy-3-(3-Diisopropylamino-1-Phenyl-Propyl)-Phenyl]-Methanol Fumarate置于raney Nickel Sodium Carbonate,Sodium Hydroxide,氢气体系中,用 二氯甲烷,水,甲醇 用作溶剂,以59%的收率获得(R)-5-羟甲基托特罗定
参考文献: A Process For Preparing Fesoterodine[fr] Procédé De Préparation De Fésotérodine
标题: A Process For Preparing Fesoterodine[fr] Procédé De Préparation De Fésotérodine
摘要:本发明涉及一种改进的制备fesoterodine及其药用盐的方法.本发明特别涉及一种制备fesoterodine及其药用盐的方法,其中涉及使用和制备r(+)苄基托特罗定和r(+)-[4-苄氧基-3-(3-二异丙基氨基-1-苯基丙基)-苯基]-甲醇富马酸盐.

海关参考信息

专利信息


专利号:WO-2017137955-A1
优先权日:2016-02-14
标题:Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol
发明人:THOMBARE PRAVIN SAHADEV
权利人:CELESTIS PHARMACEUTICALS PVT LTD
摘要:The present invention relates to novel chiral 3-(2-(allyloxy)-5-methylphenyl)-N,N-diisopropyl-3-phenylpropan-1-amine (5) and racemic 3-(2-(allyloxy)-5-methylphenyl)-N,N-diisopropyl-3-phenylpropan-1-amine () and its use in improved and industrially advantageous process for preparation of chiral and racemic form of 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol. Further, present invention relates to preparation of the same.

专利号:EP-1862449-A1
优先权日:2006-05-31
标 题 :A shortened synthesis of substituted hydroxymethyl phenols
发明人:BROWNE ROISIN; KIKELLY MICHAEL
权利人:SCHWARZ PHARMA LTD
摘要:The present disclosure relates to a process for the preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol or its phenolic monoesters or salts thereof, characterized by the steps of na) reacting a compound of formula (II)n nwith a mixture of MeMgCl and Mg in a solvent, nb) optionally reducing the temperature of the Grignard reagent to a lower temperature than in step a), and n nreacting the resulting Grignard reagent with an excess of a carbonate in a solvent, to obtain a compound of formula (III)n nwherein A is a C 1 -C 6 alkyl group, and then further reacting the compound of formula (III) in a known manner to obtain the desired end product.

专利号:US-8703996-B2
优先权日:2010-03-09
标题:Short synthesis of tolterodin, intermediates and metabolites
发明人:STERK DAMJAN
权利人:STERK DAMJAN; LEK PHARMACEUTICALS
摘要:A process is described for the preparation of intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs.

专利号:US-9751828-B2
优先权日:2014-07-30
标题:Antimuscarinic compound having a low content of impurities
发明人:ALLEGRINI PIETRO; ATTOLINO EMANUELE; GRAZIOSI RENZO
权利人:DIPHARMA FRANCIS SRL
摘要:Substantially stable to degradation Fesoterodine fumarate, a process for its preparation and a process for the synthesis of specific degradation impurities of Fesoterodine fumarate are disclosed.

专利号:US-6809214-B2
优先权日:2000-06-14
标 题 :Shortened synthesis of 3,3-diarylpropylamine derivatives
发明人:MEESE CLAUS O
权利人:SANOL ARZNEI SCHWARZ GMBH
摘要:The invention relates to a method for producing derivatives of 3,3-diarylpropylamines of general formula (I) and sterically highly pure, stable intermediate products, and to their use for producing pharmaceutical compositions.

专利号:US-8344176-B2
优先权日:2006-05-31
标 题 :Synthesis of substituted hydroxymethyl phenols
发明人:BROWNE ROISIN; KILKELLY MICHAEL
权利人:SCHWARZ PHARMA LTD; BROWNE ROISIN; KILKELLY MICHAEL
摘要:The present disclosure relates to a process for the preparation of 2-(3 -diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol or its phenolic monoesters or salts thereof, characterized by the steps of a) reacting a compound of formula (II) with a mixture of a Grignard initiator and Mg in a solvent; b) optionally reducing the temperature of the Grignard reagent to a lower temperature than in step a), and reacting the resulting Grignard reagent with an excess of a carbonate in a solvent, to obtain a compound of formula (III) wherein A is a C 1 -C 6 alkyl, and the further reacting the compound of formula (III) in a known manner to obtain the desired end product.
上海升华医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.synfarm.com
企业联系电话:021-50793966👤
📞上海升华医药科技有限公司 ⚠️参考联系方式
联系人:邱先生
电话:021-50793966
手机:18917198199
传真:021-50793967
邮箱:info@synfarm.com
通信地址: 上海浦东新区川宏路699号A2栋二楼
邮编: 201202
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海浦东新区川宏路699号A2栋二楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海美升医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.mayzem.com
电话: 18501708306; 18501708306👤
📞上海美升医药科技有限公司 ⚠️参考联系方式

销售电话:18501708306; 18501708306
邮箱:sales@mayzem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Nilvebrant L, Gillberg PG, Sparf B. Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine. Pharmacol Toxicol. 1997 Oct;81(4):169-72.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知